Keywords: xenon, w-l, sign, 58m, cholesterol, deal, genetics

Xenon and W-L sign $58M cholesterol deal

Article | 26 May 2000

Print This

Xenon Genetics of Canada has signed an agreement with Warner-Lambert toidentify novel drug targets and lead compounds for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in